FDA issued a Warning Letter to Sri Krishna Pharmaceuticals Ltd. - Unit II on 4/1/2016 as a result of this inspection.
483 Sri Krishna Pharmaceuticals - Unit II Dec 2014

483 Sri Krishna Pharmaceuticals - Unit II Dec 2014

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Sri Krishna Pharmaceuticals - Unit II - Hyderabad, Andhra Pradesh, India facility and issued 9 inspectional observations (via FDA 483) on 04 Dec 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 04 Dec 2014
  • Location: Hyderabad, Andhra Pradesh, India
  • FEI: 3005280525
Add To Cart